WisdomTree ETFs Declare Distributions
Sep 26, 2016 12:30 pm UTC| Business
NEW YORK, Sept. 26, 2016 -- WisdomTree (NASDAQ:WETF) today announced that WisdomTree declared distributions for the following WisdomTree ETFs. Rates are listed below: TickerFund NameEx-dateRecord DatePay DateOrdinary...
VirTra Receives $12.2 Million in Follow-On IDIQ Awards from U.S. Customs and Border Protection
Sep 26, 2016 12:30 pm UTC| Business
TEMPE, Ariz., Sept. 26, 2016 -- VirTra Systems, Inc.(OTC Pink:VTSI), a leading provider of use of force simulators and firearms training simulators, today announced that it has received two indefinite...
Sep 26, 2016 12:30 pm UTC| Business
PORTLAND, Ore., Sept. 26, 2016 -- Entia Biosciences, Inc. (OTCQB:ERGO) Founder and Chief Science and Technology Officer, Dr. Marvin Hausman, has reported better-than-expected preliminary results in the Company’s chronic...
Sep 26, 2016 12:30 pm UTC| Business
RADNOR, Pa., Sept. 26, 2016 -- Actua Corporation(Nasdaq:ACTA) today announced that it has entered into a definitive agreement with an investor group led by Vista Equity Partners under which it will sell GovDelivery, the...
Histogenics Corporation to Present at the 2016 Cell & Gene Meeting on the Mesa
Sep 26, 2016 12:30 pm UTC| Business
WALTHAM, Mass., Sept. 26, 2016 -- Histogenics Corporation (Histogenics) (Nasdaq:HSGX), a regenerative medicine company focused on developing and commercializing products in the musculoskeletal space, today announced...
Minerva Neurosciences Provides Update on MIN-101 and MIN-117 Clinical Programs
Sep 26, 2016 12:30 pm UTC| Business
Last patient completes extension phase of Phase IIb trial with MIN-101 Company receives FDA acceptance of Investigational New Drug Application for MIN-117 WALTHAM, Mass., Sept. 26, 2016 -- Minerva Neurosciences, Inc....
Orbus Therapeutics Announces Enrollment of First Patient in Phase 3 Trial in Late-Stage Brain Cancer
Sep 26, 2016 12:02 pm UTC| Business
PALO ALTO, Calif., Sept. 26, 2016 -- Orbus Therapeutics Inc., a private, clinical-stage biopharmaceutical company focused on the development and commercialization of therapies that treat rare diseases, today announced...